small receptor (Mr z46 kD) and has one M6P-binding site. It is believed that CDMPR exists as a dimer and/ or tetramer on the membrane. Both receptors may appear on the cell surface, where they are then internalized. CIMPR, but not CDMPR, binds extracellular ligands (von Figura and Hasilik 1986; Kornfeld and Mellman 1989; Ludwig et al. 1995; Dahms 1996; Munier-Lehmann et al. 1996b ). As to why the cells possess two MPRs, it has been demonstrated, by employing MPR-deficient fibroblasts, that each MPR preferentially binds different subgroups of lysosomal enzymes and, as a result, both receptors are required for the efficient sorting of lysosomal enzymes (Ludwig et al. 1994; Pohlmann et al. 1995; Kasper et al. 1996; Munier-Lehmann et al. 1996a) .
In contrast to the accumulated biochemical and cell biological data on the MPRs, only a few studies have appeared on the histological distribution of the two receptors (Valentino et al. 1988 (Valentino et al. ,1990 Ocrant et al. 1989; Matzner et al. 1992) . By in situ hybridization (ISH), Matzner et al. (1992) demonstrated comple-mentary expression patterns of these MPRs during mouse embryogenesis, suggesting unknown specific functions between the two MPRs. Another series of studies was performed on the immunohistochemical distribution of CIMPR as the IGF-II receptor, but not for CDMPR (Valentino et al. 1988 (Valentino et al. ,1990 Ocrant et al. 1989) . Although these studies have described the overall distribution of the MPRs in the body of rodents in some detail, their relative and precise distributions in various cell types which are located in several tissues continue to be unknown.
We have previously studied the distribution of lysosomal cysteine proteinases, cathepsins B, H, and L, in various tissues and found that they show heterogeneous distribution patterns depending on the enzymes, cells, and tissues (Uchiyama et al. 1994) . On the basis of these studies, we hypothesized that the two MPRs would also show different distribution patterns because they preferentially bind different subgroups of lysosomal enzymes (Ludwig et al. 1994; Pohlmann et al. 1995; Munier-Lehmann et al. 1996a ). To test this hypothesis, we carefully investigated the tissue distribution of the two MPRs in the rat liver, using immunohistochemical (IHC) and in situ hybridization (ISH) methods. The collective findings indicate differences in the distribution patterns of the two receptors in the rat liver.
Materials and Methods

Animals and Tissue Preparation
Four adult male Wistar rats (7 weeks of age, ‫ف‬ 250 g) were deeply anesthetized with pentobarbital (25 mg/kg IP) and perfused via the portal vein first with 5 ml of physiological saline and then with 50 ml of 4% paraformaldehyde buffered with 0.1 M phosphate buffer (PB), pH 7.4, containing 4% sucrose. The liver tissue was excised, cut into small pieces, and immersed in the same fixative for 4 hr. After washing three times with the same buffer containing 7.5% sucrose, cryoprotection was ensured by infusing successively with 15% and 30% sucrose solutions, after which they were embedded with OCT compound. Cryosections were cut in 10-m sections with a cryostat (Coldtome CM 501; Sakura, Tokyo, Japan) and mounted on gelatin-coated glass slides.
Antibodies
A rabbit polyclonal antibody against rat CIMPR was raised as reported previously (Muno et al. 1993 ). An anti-CDMPR antibody was raised by immunizing rabbits with a synthetic peptide, the sequence of which corresponded to the cytoplasmic portion of CDMPR (KGMEQFPHLAFWQDL) as previously reported (Nadimpalli et al. 1991; Kanamori et al. 1998) . Briefly, the peptide was synthesized by Bio-Synthesis (Lewisville, TX), purified by reverse-phase HPLC on Purosphere RP-18 (Cica-MERCK; Darmstadt, Germany), and confirmed by amino acid analysis. To immunize rabbits, the peptide was conjugated to keyhole limpet hemocyanin by reacting it with dimethyl adipimidate. The antiserum was purified by affinity chromatography using the synthetic peptide coupled to NHS-activated sepharose (HiTrap; Amersham Pharmacia Biotech, Poole, UK). An antibody against the entire cytoplasmic domain of CDMPR (MSCI-III-7b) was kindly provided by Dr. A. Hill-Rehfeld (Georg-August-University; Göttingen, Germany). The following mouse monoclonal antibodies were purchased and used in this study: ED2 and OX6 (SEROTEC; Oxford, UK), and the anti-GFP antibody (Roche Diagnostics; Mannheim, Germany).
cDNAs and Probes
The cDNA for rat CDMPR was cloned into the Not I site of Bluescript II SK ϩ (Stratagene; La Jolla, CA) as previously described (Kanamori et al. 1998) . A Pst I fragment, containing the 5 Ј non-translated region, the entire coding region (834 bp), and a portion of the 3 Ј -non-translated region (411 bp) was subcloned into Bluescript II SK ϩ to prepare the probe for ISH. The fusion protein CDMPR-GFP, which contains a variant of green fluorescent protein (GFP), GFP-S65T, at the C-terminus of CDMPR, was constructed in pcDNA3 vector (Invitrogen; Carlsbad, CA) by a PCR-based method. A 879-bp fragment of rat CIMPR cDNA, containing a portion of the luminal domain (174 bp), the transmembrane and cytoplasmic domains (567 bp), and a portion of 3 Ј non-translated region, was amplified by RT-PCR from the total RNA of adult rat pituitary using the following oligonucleotides: upstream primer, ATCGGATCCATCTTCTTCCACTGT-GACCC; downstream primer, ATCGAATTCCCCCATTAC-AGAAACTTCCC. The fragment was cloned into Bluescript II SK ϩ vector at the BamHI-EcoRI restriction site. The PCR fragment was verified by sequencing. Rat cathepsin L cDNA was kindly provided by Dr. K. Ishidoh (Ishidoh et al. 1987) . Its EcoRI-BamHI fragment (856 bp) was subcloned into Bluescript II SK ϩ vector.
Immunofluorescence Microscopy
The liver sections were treated with methanol at room temperature (RT) for 15 min and then incubated with 2% normal goat serum at RT for 20 min. They were then incubated with the following primary antibodies at 4C overnight: anti-CIMPR (1.9 g/ml), anti-CDMPR (1 g/ml), MSCI-III-7b (1:1000), ED2 (1:500), and OX6 (1:200). Further incubation was performed with FITC-conjugated goat anti-rabbit IgG (1:1000; Seikagaku Kogyo, Tokyo, Japan) or Texas Red-conjugated goat anti-mouse IgG (1:1000; Biomeda; Foster City, CA) at RT for 1 hr. For double immunofluorescence, the sections were immunolabeled first for ED2 or OX6 and then for CIMPR or CDMPR, as described above. After each step, sections were rinsed with 0.01 M phosphate buffered 0.5 M saline (pH 7.2), containing 0.1% Tween-20 (Sigma Chemical; St Louis, MO). For control experiments, sections were incubated either with a non-immunized rabbit serum diluted to 1:1000 or with a dilution buffer, followed by incubation with FITC-conjugated goat anti-rabbit IgG or Texas Red-conjugated goat anti-mouse IgG. For the cultured cells, CDMPR-GFP was transiently expressed in HeLa cells by transfection using the calcium-phosphate method as described previously (Alconada et al. 1996) . After expression for 24 hr, the cells were fixed with 3% paraformaldehyde/ PBS at RT for 15 min, washed with PBS, and incubated with 10% normal goat serum/PBS. They were then labeled with rabbit anti-CDMPR and mouse anti-GFP antibodies at RT for 30 min, followed by incubation with FITC-conjugated goat anti-mouse IgG and Texas Red-conjugated goat antirabbit IgG at RT for 30 min. The immunofluorescence signal was viewed with a confocal laser microscope, LSM-GB200 (Olympus; Tokyo, Japan) or LSM510 (Carl Zeiss; Jena, Germany).
In Situ Hybridization
Bluescript II SK ϩ plasmids encoding each cDNA were linearized by digesting at convenient restriction sites on either side of the inserts. Digoxigenin (DIG)-labeled cRNA probes were then synthesized using an RNA labeling kit (Roche Diagnostics; Mannheim, Germany) according to the manufacturer's recommended protocol.
The liver sections were prehybridized in a hybridization buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 600 mM NaCl, 0.25% SDS, 50% deionized formamide, 10% dextran sulfate, 20 g/ l tRNA from E. coli , 1 ϫ Denhardt's solution) at 50C for 1 hr, and then hybridized with DIG-labeled probes in the same buffer at 50C for 20 hr. After washing with 50% formamide in 2 ϫ SSC at 50C for 30 min, the sections were treated with 1 g/ml ribonuclease A at 37C for 30 min. They were then washed once with 2 ϫ SSC at 50C for 20 min and twice with 0.2 ϫ SSC at 50C for 20 min. The signal was detected using a DIG Nucleic Acid Detection Kit (Roche Diagnostics).
Immunoblot Analysis
The rat liver tissue was homogenized with a cell lysis buffer solution (0.05 M Tris-HCl, pH 7.5, 0.15 M NaCl, 1% NP-40, 0.5% deoxycholate, 1 mM EDTA) containing a protease inhibitor cocktail (Roche Diagnostics). After centrifugation at 15,000 ϫ g for 15 min, the supernatant was subjected to 10% SDS-PAGE under non-reduced conditions and the proteins were then transferred onto a PVDF membrane (Immobilon; Millipore, Bedford, MA). The blots were immunolabeled with anti-CIMPR or anti-CDMPR antibody, followed by HRP-conjugated anti-rabbit IgG. The signals were detected using ECL reagents (Amersham Pharmacia Biotech).
Immunoprecipitation
HeLa cells transiently expressing CDMPR-GFP and control cells were incubated with methionine-free DMEM (Life Technologies; Rockville, MD) containing 10% dialyzed FBS for 30 min, followed by an incubation with 10 mBq/ml of Redivue PRO-MIX (Amersham Pharmacia Biotech) in the same medium overnight. After washing three times with PBS, the cells were lysed with cell lysis buffer that contained a protease inhibitor cocktail. The resulting lysates were precleared with protein A-Sepharose CL4B (Amersham Pharmacia Biotech) for 1 hr at 4C and centrifuged for 15 min. The supernatant was incubated, first with anti-CDMPR or anti-GFP antibody overnight at 4C and then with protein A-Sepharose CL4B for 1 hr at 4C. After washing the Sepharose, the immune complexes in the SDS gel sampling buffer was boiled for 5 min, and then electrophoresed on a 10% SDS-polyacrylamide gel. The gel was fluorographed and imaged using BAS2000 (Fuji Film; Tokyo, Japan).
Results
Characterization of the Antibodies Used in This Study
The specificity of anti-rat CIMPR antibody has previously been demonstrated by immunoprecipitation and immunofluorescence microscopy (Waguri et al. 1995; Muno et al. 1993) . By immunoblotting analysis of liver extracts, the antibody was found to recognize a single band for CIMPR at ‫ف‬ 300 kD under non-reduced conditions ( Figure 1A) . The reduced form of CIMPR was not recognized by this antibody (data not shown). In contrast, anti-CDMPR recognized neither the reduced nor the non-reduced form of CDMPR in our immunoblotting system. To further characterize this antibody, HeLa cells transiently expressing the CDMPR-GFP fusion protein were analyzed by immunoprecipitation. As shown in Figure 1B , the antibody recognized both the endogenous CDMPR ( ‫ف‬ 46 kD) and the transiently expressed CDMPR-GFP (two bands around ‫ف‬ 70 kD). The lower sharp band corresponding to CDMPR-GFP probably represents the non-palmitoylated form, as has been reported previously (Schweizer et al. 1996) . The specificity of the antibody was also confirmed by immunofluorescence microscopy ( Figure 1C) ; the cells expressing CDMPR-GFP showed a more intense signal for the antibody than the non-expressing cells ( Figure 1C ; anti-CDMPR), and the GFP signal was completely overlapped with the immunofluorescence signal, which was stained with anti-CDMPR, especially in the perinuclear Golgi region ( Figure 1C ; merge). We therefore conclude that the antibodies used in this study tend to recognize the folded forms of MPRs and are applicable to immunofluorescence microscopy.
Distribution of the Two MPRs in the Rat Liver
As shown in Figures 2A and 2C , a strong granular immunofluorescence signal for CIMPR was detected in hepatocytes, whereas the signal was faint in sinusoidal cells. A weak but distinct signal was also detected on the cell surface of hepatocytes. In the acinus, the intensity was higher in perivenous than in periportal hepatocytes (Figure 2A ). Positive staining for CIMPR was also detected in interstitial cells and in the epithelial cells of interlobular bile ducts, which are located in the portal triad, although this intensity was lower than that found in hepatocytes ( Figure 2E ). Granular staining for CDMPR was detected in both hepatocytes and sinusoidal cells. The latter were much more intensely immunoreactive than the former ( Figures 2B and 2D ).
No clear-cut difference in immunofluorescence intensity was detected in hepatocytes with respect to their location within the acinus ( Figure 2B ). In the case of Glisson's capsule, a positive signal for CDMPR was detected in the epithelial cells of interlobular bile ducts and the intensity was higher than that in the hepatocytes. Some interstitial cells, including fibroblast-like cells, also showed distinct signals for CDMPR (Figures 2F and 5C ). The same staining patterns were obtained when the antibody MSCI-III-7b, which recognizes the entire cytoplasmic domain of CDMPR, was used (data not shown).
The preferential localization of CIMPR and CD-MPR in hepatocytes and sinusoidal cells was also confirmed by ISH. As shown in Figure 3 , the majority of the CIMPR transcript was detected in hepatocytes ( Figure 3A) , whereas the expression level of CDMPR mRNA was higher in sinusoidal cells than in hepatocytes ( Figure 3B ). The distribution pattern of the CD-MPR transcript was similar to that of cathepsin L ( Figure 3C ), which has been shown to exist at higher levels in Kupffer cells than in hepatocytes (Watanabe et al. 1989 ).
Identification of CDMPR-positive Cells
We next attempted to identify the CDMPR-positive cells in the sinusoid and Glisson's capsule using the MAbs, ED2 and OX6, which are known to serve as markers for Kupffer cells (Dijkstra and Damoiseaux 1993) and antigen-presenting cells (Prickett et al. 1988; Steinman 1991; Matsuno et al. 1995) , respectively. Double immunofluorescence microscopic observations showed that CDMPR-positive cells within the sinusoid were also ED2-positive, indicating that these cells are Kupffer cells (Figures 4C and 4D ). ED2-positive cells showed almost no signal for CIMPR ( Figures 4A and 4B) . In the Glisson's capsule, immunoreactivity for CDMPR was detected in OX6-positive cells, although its intensity was lower than those in fibroblast-like cells ( Figures 5C and 5D ). CIMPR immunoreactivity was weak or faint in the OX6-positive cells ( Figures 5A and 5B ).
Discussion
The present study demonstrates that CI-and CDMPR are expressed at different levels and locations in the rat liver. The former was distributed mainly in hepatocytes, whereas the latter was localized in non-hepatocytic cells, such as Kupffer cells and antigen-presenting cells (APCs).
In a previous study, Matzner et al. (1992) suggested, on the basis of ISH experiments, that unknown specific functions are operative between the two MPRs during mouse embryogenesis, in that complementary expression patterns were observed. This notion is essentially consistent with the present results. By comparing the distribution of two MPRs in the rat liver, their expression patterns were found to be rather tissue-selective. CDMPR was intensely expressed in nonhepatocyte cells, such as Kupffer cells, APCs, and the epithelial cells of interlobular bile ducts, whereas CIMPR was expressed mainly in hepatocytes. This contrast suggests that CDMPR plays important roles in lysosomal enzyme trafficking in non-hepatocyte cells of the liver. Promoter analyses of human and mouse CDMPR genes have shown that they contain CpG islands and lack a TATA box, suggesting that CDMPR is expressed constitutively as a housekeeping gene (Klier et al. 1991; Ludwig et al. 1992) , whereas the expression of CIMPR is regulated by several transcription factors (Liu et al. 1995) . Such gene characteristics of CDMPR may correspond with its rather broad expression in rat liver tissue. However, the higher expression of CDMPR observed in Kupffer cells suggests that it is not merely a housekeeping gene but rather that its expression is regulated by unknown mechanisms in the liver tissue in a cell-specific manner.
It has been shown that the cathepsin L family of proteinases, such as cathepsins K and S, play important roles in bone absorption and antigen processing in osteoclasts and APCs, respectively (Saftig et al. 1998; Nakagawa et al. 1999; Shi et al. 1999 ). It has also been shown that cathepsin L is localized in Kupffer cells of the liver and macrophages in the lung and intestine (Ii et al. 1985; Watanabe et al. 1989; Furuhashi et al. 1991; Ishii et al. 1991 ). The present results, using ISH, confirmed that cathepsin L mRNA was specifically detected in Kupffer cells. Kupffer cells and APCs are involved in the defense and immune systems in the liver and therefore require the expression of the cathepsin L family of proteinases. As stated above, CDMPR was preferentially expressed in these mononuclear cell-derived cells in liver tissue. This result is consistent with previous biochemical studies in which mouse cathepsin L, also known as MEP (major excreted protein), showed a low binding affinity for CIMPR (Dong et al. 1989; Dong and Sahagian 1990; Lazzarino and Gabel 1990) . Therefore, it is likely that CDMPR is mainly involved in the sorting of cathepsin L in these cells. Until recently, no remarkable histological and functional disorders have been shown in CD-MPR-deficient mice, except for a partial misrouting of lysosomal enzymes (Köster et al. 1993; Ovitt et al. 1993) , suggesting that the role of CDMPR in Kupffer cells and APCs may be compensated by CIMPR. More precise studies of the morphological and functional aspects of these cells will be required using deficient mice.
There have been several studies concerning interactions of both MPRs with M6P. In equilibrium dialysis binding studies, and have revealed that CIMPR contains two binding sites for M6P per monomer, whereas CD-MPR binds one molecule of M6P per monomeric subunit. Therefore, it was assumed that differences in the phosphorylation state of oligosaccharides, which are attached to the lysosomal enzymes, determine the preferential binding of lysosomal enzymes to either MPRs. This hypothesis was tested using MPRs-deficient fibroblasts re-expressing CI-or CDMPR. By characterizing phosphorylated oligosaccharides of lysosomal enzymes secreted from these fibroblasts, Munier-Leh- et al. (1996a) have shown that CIMPR preferentially binds enzymes that have oligosaccharides with two phosphomonoesters, whereas CDMPR tends to bind enzymes that have multiple oligosaccharides with one phosphomonoester. Moreover, they have shown that the two MPRs appear to transport different isoforms of cathepsin D, which is known to be sorted more efficiently by CIMPR than by CDMPR (Ludwig et al. 1994; Pohlmann et al. 1995) . However, another study that examined the oligosaccharides of secreted cathepsin D has demonstrated that little difference is detected in the phosphorylation state of the secreted enzyme between the fibroblasts that express CI-or CDMPR and, furthermore, that oligosaccharides with two phosphomonoesters represent the major oligosaccharide species (Dittmer et al. 1997) . Although the discrepancy between these two results has not been explained, Dittmer et al. (1997) have suggested that other parameters, including the structure of the underlying oligosaccharides, the position of the phosphorylated mannose residues within the oligosaccharides, and the polypeptide backbone, would determine the affinity of the enzyme for the two MPRs. When we consider these notions, our present results could indicate that the difference in affinity of the two MPRs for each lysosomal enzyme contributes to the different distribution patterns of the MPRs, because lysosomal enzymes also show heterogeneous distribution patterns depending on enzymes, cells, and tissues (Uchiyama et al. 1994) . However, more information concerning differences in the oligosaccharide modification and the phosphorylation state of lysosomal enzymes for several types of cells and tissues will be needed.
As stated above, CIMPR is mainly expressed in hepatocytes, suggesting the importance of this receptor in the cells. In addition to its sorting function of M6P-containing lysosomal enzymes in the TGN, CI-MPR has also been shown to bind several ligands on the cell surface. It is involved in the downregulation of the extracellular IGFII levels (Ludwig et al. 1995) and in the activation of TGF-␤ (Dennis and Rifkin 1991). Moreover, retinoic acid has also been shown to bind CIMPR, leading to the redistribution of the receptor (Kang et al. 1997 (Kang et al. ,1998 . Therefore, hepatocytes are involved in the quantitative regulation of biologically active factors via the expression of CIMPR. In addition to these physiological functions of CIMPR in hepatocytes, it is also known to be a tumor suppressor molecule and, in fact, the loss of the CIMPR gene is frequently found in hepatocellular carcinoma (Piao et al. 1997; Yamada et al. 1997) .
The distribution of CIMPR within the liver acinus is also intriguing. Its expression was high in the perivenous region compared to the periportal region. This staining pattern is in agreement with our previous results, in which the same distribution patterns of lysosomal cysteine proteinases, cathepsins B and H, in the rat liver acinus were demonstrated (Waguri et al. 1990 ). These lines of evidence suggest that the predominant proteolytic activity in lysosomes is also ensured by the higher expression of CIMPR in perivenous hepatocytes and, furthermore, that cathepsins B and H may be transported mainly by CIMPR, at least in the hepatocytes of rat liver.
Collectively, the present data, which show that the expression of CIMPR was predominant in hepatocytes whereas that of CDMPR was prominent in Kupffer cells and APCs, suggest that the two MPRs possess different functions in the rat liver.
